Etaracizumab (LM 609), an alphavbeta3 integrin IgG1 monoclonal antibody, effectively inhibits angiogenesis and melanoma tumor growth, offering a potential avenue for anticancer research [1].
Molecular Weight:
144.3 (kDa)
CAS Number:
[892553-42-3]
* VAT and and shipping costs not included. Errors and price changes excepted
